Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives $52.77 Consensus Target Price from Brokerages
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) has received an average rating of “Moderate Buy” from the fourteen research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, eleven have assigned a buy recommendation and one has […]
2 Aug 11:28 · The Markets Daily